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a  b  s  t  r  a  c  t
Cardiac  progenitors,  such  as  cardiospheres  and cardiosphere-derived  cells,  represent  an attractive  cell
source for  cardiac  regeneration.  The  PIWI-interacting  RNAs,  piRNAs,  are  an  intriguing  class  of small  non-
coding  RNAs,  implicated  in the  regulation  of epigenetic  state,  maintenance  of  genomic  integrity  and  stem
cell functions.  Although  non-coding  RNAs  are  an exploiting  ﬁeld  in cardiovascular  research,  the piRNA
signatures  of cardiac  progenitors  has  not  been  evaluated  yet.We  proﬁled,  through  microarrays,  15,311
piRNAs  expressed  in  cardiospheres,  cardiosphere-derived  cells  and  cardiac  ﬁbroblasts.  Results  showed  a
set  of  differentially  expressed  piRNAs  (fold change  ≥2,  p <  0.01):  641  piRNAs  were  upregulated  and  1,301
downregulated  in the  cardiospheres  compared  to  cardiosphere-derived  cells,  while  255  and  708  piRNAs
resulted  up-  and  down-regulated,  respectively,  if compared  to cardiac  ﬁbroblasts.  We  also  identiﬁed  181
piRNAs  that  are  overexpressed  and  129  are  downregulated  in  cardiosphere-derived  cells  respect  to  car-
diac  ﬁbroblasts.Bioinformatics  analysis  showed  that the  deregulated  piRNAs  were  mainly  distributed  on
few chromosomes,  suggesting  that  piRNAs  are  organized  in  discrete  genomic  clusters.Furthermore,  the
bioinformatics  search  showed  that the  most  upregulated  piRNAs  target  transposons,  especially  belonged
to  LINE-1  class,  as validated  by qRT-PCR.  This  reduction  is  also  associated  to an  activation  of  AKT  signal-
ing,  which  is  beneﬁcial  for cardiac  regeneration.The  present  study  is  the  ﬁrst  to  show  a highly  consistent
piRNA  expression  pattern  for human  cardiac  progenitors,  likely  responsible  of their different  regen-
erative  power.  Moreover,  this  piRNome  analysis  may  provide  new  methods  for  characterize  cardiac
progenitors  and may  shed  new  light on  the  understanding  the  complex  molecular  mechanisms  of  cardiac
regeneration.
© 2016  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Cardiovascular diseases are the leading cause of mortality and
orbidity in the developed world (Nichols et al., 2014; Yeh et al.,
010), partly because mammals are not able to regenerate heart
issue (Aguirre et al., 2013). The presence of myocardial scarring
Abbreviations: MI, myocardial infarction; CPC, cardiac progenitor cells; CS,
ardiospheres; CDC, cardiosphere-derived cells; ncRNA, non-coding RNA; piRNA,
IWI-interacting RNA; CF, cardiac ﬁbroblasts; RT, retrotransposons.
∗ Corresponding author at: Fondazione Ri.MED, Department of Laboratory
edicine and Advanced Biotechnologies, IRCCS- ISMETT, via Tricomi 5, 90127
alermo, Italy.
E-mail address: sevella@ismett.edu (Vella S.).
ttp://dx.doi.org/10.1016/j.biocel.2016.04.012
357-2725/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article u
http://creativecommons.org/licenses/by-nc-nd/4.0/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
predisposes to unfavourable left ventricular remodelling and heart
failure (Yeh et al., 2010). The ﬁnal goal of regenerative medicine
for myocardial infarction (MI) is to reduce the scar formation,
rebuilding a healthy heart muscle. In the absence of curative
treatments, innovative biotechnological approaches aim to induce
cardiac regeneration in patients with MI  or heart failure, by deliver-
ing nucleic acids, recombinant proteins, or cells. Interestingly, the
discovery of cardiovascular progenitor cells (CPC) in adult hearts
has provided candidates for cell therapy approach (Wu et al., 2008),
with some preclinical evidence for efﬁcacy in cardiac repair and
functional improvement after MI  through both direct and indi-
rect mechanisms (Chimenti et al., 2010). Following MI, resident
CPC migrate from the niches to the site of injury, proliferate and
ﬁnally differentiate into functional cardiomyocytes. At the same
nder the CC BY-NC-ND license
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ime, the paracrine secretion of growth factors, cytokines and reg-
lating nucleic acids is strongly involved in CPC-induced beneﬁcial
ffects (Barile et al., 2014). CPC derived from human atrial or ven-
ricular biopsies as well as from murine hearts were primarily
escribed by Messina et al. (2004) (Chimenti et al., 2010,2012).
hese progenitors can be maintained in suspension as undiffer-
ntiated self-adherent 3D-clusters, called “cardiospheres” (CS), or
dapting them to adherent plates as cardiosphere-derived cells
CDC). Interestingly, CS mimic  a stem cell niche-like microenvi-
onment with a high proportion of c-KIT+ cells and upregulated
xpression of SOX2, NANOG, and adhesion/extracellular (ECM)
atrix molecules (Li et al., 2010). Dissociation of CS into single cells
nd their expansion in monolayers (CDC) decrease the expression
f ECM molecules (Li et al., 2010) and reduce the heterogeneity
f the cell population ameliorating the reliability of the in vitro
nalysis. Remarkably, CDC have been recently used in a phase 1
linical trial (CADUCEUS), showing good results in term of safety
nd some evidences of therapeutic cardiac regeneration (Makkar
t al., 2012).
For decades it had been supposed that heart loses the abil-
ty to regenerate after birth. On the contrary, recent studies have
emonstrated that the capacity of cardiac repair is not totally lost
n adults, where endogenous regeneration, after cardiac injury, is
ersistent, even if at a very low rate (Zhang et al., 2015). However,
he cellular and molecular mechanisms of cardiac regeneration
emain still unclear. Recently it has been demonstrated that dif-
erent classes of non-coding RNA (ncRNAs) are involved in the
ontrol of the gene regulatory programs in heart development and
isease (Ounzain et al., 2013; Philippen et al., 2015; Wu et al.,
013).
Particularly, microRNAs have been described to play critical
oles in cardiogenesis, regulation of cardiomyocyte proliferation
nd progress of cardiovascular diseases (Aguirre et al., 2014; Barile
t al., 2014; Eulalio et al., 2012; Mathieu and Ruohola-Baker, 2013;
lson, 2014). PIWI-interacting RNAs (piRNA) are another fam-
ly of ncRNAs whose importance in gene expression regulation
s now increasingly evaluated (Iwasaki et al., 2015; Moyano and
tefani, 2015; Weick and Miska, 2014). piRNAs are ncRNAs of
6–32 nucleotides in length involved in the maintenance of genome
ntegrity by modulating the expression of retrotransposons (Aravin
t al., 2006, 2007; Brennecke et al., 2007; Girard et al., 2006; Moyano
nd Stefani, 2015; Watanabe et al., 2006), which span around 40%
f the eukaryotic genome. PiRNAs are generated within unanno-
ated heterochromatic regions of the genome, where transposons
nd repetitive elements are also present (Samji, 2009; Seto et al.,
007). Recent evidence demonstrate that piRNAs are also expressed
n somatic cells (Sharma et al., 2001), including cardiomyocytes.
oreover, it has been recently highlighted that miRNAs and piRNAs
nﬂuence AKT signaling pathway (Rajan et al., 2014), a crucial net-
ork in heart physiopathology (Lin et al., 2015). Thus, piRNAs could
lay a functional role in cardiomyocyte proliferation and regener-
tion, apart from that already proven for miRNAs (Pisano et al.,
015). Conﬁrming an effect of piRNAs on AKT pathway could pro-
ide insights for innovative diagnostic and therapeutic approaches
or cardiovascular diseases.
To investigate this hypothesis, the assessment of piRNome in
ifferent cardiac cell types is of primarily importance. Here, we
ompare the piRNome of CDC, CS and cardiac ﬁbroblasts (CF) (i.e.
ardiac cells with different regenerative potential), obtained from
eart bioptic samples of adult patients undergoing cardiac surgery.
Our results demonstrate that their piRNA expression proﬁles
igniﬁcantly differ in the three cell types, identifying a speciﬁc sig-
ature. Moreover, the results of our experiments provide evidence
hat piRNome in cardiac progenitors is associated with inhibition
f LINE-1 and activation of the prosurvival AKT signaling.hemistry & Cell Biology 76 (2016) 1–11
2. Materials and methods
2.1. Biopsy specimen processing and cell culture
CPC were obtained by right atrial specimens collected by
patients undergoing cardiac surgery. The study was approved
by the local Ethical Committee and all patients gave written
informed consent to the collection. The investigation conforms to
the declaration of Helsinki. For patient characteristics see Sup-
plementary Table 1. CS and CDC were obtained and cultured
from biopsies as previously described (Messina et al., 2004).
Brieﬂy, biopsies were cut into small fragments, removing con-
nective tissue, then washed and enzymatically digested (0.025%
Trypsin-EDTA, Sigma-Aldrich, Milan, Italy). The tissue fragments
were cultured as “explants” on dishes coated with ﬁbronectin
(BD Biosciences, Franklin Lakes, NJ). After several days, a layer
of stromal like cells arose from adherent explants over which
small, round, phase-bright cells migrated. Once conﬂuent, the cells
surrounding the explants were harvested by enzymatic digestion
(0.05% Trypsin-EDTA, Sigma-Aldrich). These cardiosphere-forming
cells were seeded on poly-d-lysine- coated ﬂasks (Sigma-Aldrich)
in CS medium. Several days later, cells that remained adher-
ent to the poly-d-lysine-coated dishes were discarded, whereas
detached cardiospheres (CS) were plated on ﬁbronectin coated
dishes and expanded as monolayers. CDC were subsequently pas-
saged in CS, for a maximum of 5 times. CDC were cultured in
IMDM (Iscove’s Modiﬁed Dulbecco’s Medium, Sigma-Aldrich) sup-
plemented with 100 Units/ml penicillin G, 100 g/ml streptomycin,
2 mmol/L l-glutamine (Sigma-Aldrich) and 20% FCS (Lonza, Basel,
Switzerland). The CS medium was 35% IMDM/65% DMEM:HAM-
F12 (Sigma-Aldrich) with 100 Units/ml penicillin G, 100 g/ml
streptomycin, 2 mmol/L l-glutamine (Sigma-Aldrich), 3.5% FCS, 4%
B27 (Gibco, Milan, Italy), 20 ng/ml bFGF (basic Fibroblast Growth
Factor, PeproTech, London, UK), 10 ng/ml EGF (Epidermal Growth
Factor, PeproTech), 40 nmol/L Cardiotrophin-1 (PeproTech) and
40 nmol/L thrombin (Sigma-Aldrich). From the same biopsies, CF
were isolated and cultured in DMEM (Sigma-Aldrich), supple-
mented with l-glutamine, penicillin/streptomycin (Sigma-Aldrich)
and 10% FCS (Lonza).
2.2. piRNA microarray analysis and statistics
Total RNA was  extracted from each sample with the RNeasy
kit (Qiagen, Valencia, CA) and then treated with DNase. RNA was
labelled with Cy-3 and hybridized to Human HG19 piRNA Expres-
sion Oligo microarrays (ArrayStar, Rockville, MD)  containing probes
for 23,000 piRNAs selected from the National Center for Biotech-
nology Information (NCBI) database and mapped to the HG19
genome sequence using UCSC Blat. Then the arrays were scanned
with Agilent DNA Microarray Scanner G2505C. A transcript was
considered detectable if the signal intensity was higher than 3
times the maximal background signal and the spot coefﬁcient of
variation (SD/signal intensity) was  <0.5. The expression data ﬁles
obtained by the Agilent Feature Extraction Software were imported
into GeneSpring GX software. The differentially expressed piR-
NAs were identiﬁed by fold-change screening with a threshold of
2 fold (Fig. 2A). Statistically signiﬁcant differences between the
groups were identiﬁed by GeneSpring statistics based on the t prob-
ability value method with high stringency (probability value of
0.001 to decrease the false-positives). Signiﬁcant and differentially
expressed piRNAs were identiﬁed through Volcano Plot ﬁltering
(Fig. 2B). Hierarchical clustering was performed using the Agilent
GeneSpring GX software (version 12.1).
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Fig. 1. piRNA proﬁle in cardiospheres, cardiosphere-derived cells and cardiac ﬁbroblasts.
A  Repr
5 ﬁle c
g
2
l
B
p
u
o
s
c
s
f
t
2
m
u
u
2
c
S
i
b
B) Schematic representation of workﬂow of piRNA-screening in CS, CDC and CF. B)
0  M. C) RNAs evaluation by denaturing agarose gel electrophoresis. D) piRNA pro
roup).
.3. Bioinformatics
To obtain a chromosome-wide piRNA distribution, the genomic
ocus for each piRNA was  determined from piRNABank (Institute of
ioinformatics and Applied Biotechnology, Bangalore, India; http://
irnabank.ibab.ac.in). In addition, we analysed the targets of the
pregulated piRNAs in CS, CDC and CF, using a modiﬁed version
f miRanda in piRNABank. Each piRNA was searched for repeat
equence targets against the transposon database of the human
hromosomes (NCBI Human Genome Build 36) across a repre-
entative 100,000 base stretch (position 1–100,000) with a mean
ree energy maximum of 20.0 kcal/mol and a very stringent score
hreshold of 140.
.4. Real-Time RT-quantitative PCR (qRT-PCR)
Quantitative RT-PCR (qRT-PCR) was performed to validate the
icroarray results. Total RNA was isolated from CDC, CS and CF,
sing miRNeasy mini kit (Qiagen, Germany), according to the man-
facturer’s instructions.
.4.1. Characterization of cell types
Reverse transcription was performed using the High-Capacity
DNA Reverse Transcription Kit (Life Technologies, Thermo Fisher
cientiﬁc, Waltham, MA,  USA) according to the manufacturer’s
nstructions to obtain cDNA. Gene expression was quantiﬁed
y qRT-PCR using StepOnePlus Real-Time instrument (Applied
iosystems, Thermo Fisher Scientiﬁc) using TaqMan or Sybr Greenesentative photomicrographs of the three cell types. Magniﬁcation 10X. Scale bar:
omparison by box plot of log2 ratios distributions of piRNA datasets (n = 5 for each
methods. TaqMan gene assays (Life Technologies, Thermo Fisher
Scientiﬁc) for DDR2 (Hs01025953 m1), CD90 (Hs00174816 m1),
CD45 (Hs00365634 g1), CD31 (Hs00169777 m1), VIM
(Hs00958113 g1), CD105 (Hs00923996 m1), cTNT
(Hs00943911 m1), CX43 (Hs00748445 s1), SMA  (Hs00426835 g1)
and GAPDH (Hs02758991 g1) were used. The sequences
of forward and reverse primers for Sybr Green method
were: FLK1 Forward 5′-AGCCTTCAGATGCCACAGAC-
3′ and Reverse 5′-ACAACCAGACGGACAGTGGT-3′;
GATA4 Forward 5′-CTGTGCCCGTAGTGAGATGA-3′ and
Reverse 5′-TCCAAACCAGAAAACGGAAG-3′; ISL1 For-
ward 5′-ATTTCCCTATGTGTTGGTTGCG-3′ and Reverse
5′-CGTTCTTGCTGAAGCCGATG-3′; GAPDH Forward
5′-ACCAGGAAATGAGCTTGACAAA-3′ and Reverse 5′-
CGAGATCCCTCCAAAATCAA-3′. GAPDH was used as a reference
gene for the relative quantiﬁcation, assessed by 2−CT calcu-
lation for each mRNA. The samples were run in duplicate and
template-negative reactions served as controls.
2.4.2. Analysis of piRNAs
The TaqMan small RNA assays for piRNAs were custom designed
(by Life Technologies, Thermo Fisher Scientiﬁc). DNase I–treated
total RNA (1000 ng) were reverse-transcribed using the TaqMan
MicroRNA Reverse Transcription Kit (Applied Biosystems, Thermo
Fisher Scientiﬁc) following the manufacturer’s protocol, with minor
modiﬁcations as described (Lee et al., 2011). Expression of piR-
NAs was quantiﬁed by TaqMan RT-PCR using ABI PRISM 7900 Fast
instrument (Applied Biosystems, Thermo Fisher Scientiﬁc) with
4 S. Vella et al. / The International Journal of Biochemistry & Cell Biology 76 (2016) 1–11
Fig. 2. Differentially expressed piRNAs in CS, CDC and CF.
A) Scatter plot of piRNA expression variation between the sample groups (n = 5 for each group). The values of X and Y axes are averaged normalized values in each group
(log2  scaled). The green lines are fold-change lines (the default fold-change value given is 2). piRNAs above and below the green lines showed >2 fold increase or decrease,
respectively, between pairs. B) Volcano plot of fold-change and corresponding p values for each piRNAs after comparison of the two sample groups (n = 5 for each group). C)
Hierarchical clustering based on the expression levels of piRNAs in CS, CDC and CF (n = 5 for each group). The dendrogram shows the relationships among piRNA expression
patterns: “red” indicates high relative expression, “blue” low relative expression. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the  web  version of this article.)
of Bioc
a
u
b
d
2
c
S
i
q
U
t
t
p
T
e
c
o
i
m
t
2
w
c
2
B
c
I
M
(
c
q
F
(
l
i
o
C
C
S
T
c
A
i
R
b
h
G
2
R
D
S
(
d
u
c
iS. Vella et al. / The International Journal 
ssays designed by Life Technologies. U6 snRNA (001973) was
sed as a reference gene for the relative quantiﬁcation, assessed
y 2−CT calculation for each piRNA. The samples were run in
uplicate and template-negative reactions served as controls.
.4.3. Analysis of L1 RNA transcripts
Reverse transcription was performed using the High-Capacity
DNA Reverse Transcription Kit (Life Technologies, Thermo Fisher
cientiﬁc, Waltham, MA,  USA) according to the manufacturer’s
nstructions to obtain cDNA. cDNAs were subsequently analyzed by
RT-PCR in a total volume of 20 l mixture containing 1X TaqMan
niversal MasterMix II (Life technologies, Thermo Fisher Scien-
iﬁc), 900 nM of each primer and 180 nM of TaqMan probe. For
he quantiﬁcation of L1 RNA transcripts, we used the primers and
robes listed in Table 1, as already described (Coufal et al., 2009).
he 5′-UTR primers/probe set is useful for the evaluation of the
xpression level of full-length transcripts, while the ORF2 oligonu-
leotides set provides an estimation of full-length transcripts plus
ther 5′ truncated LINEs. The samples were normalized accord-
ng to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
RNA (Hs99999905 m1,  Life Technologies, Thermo Fisher Scien-
iﬁc) levels. The expression fold change was calculated by the
−CT method for each of the reference genes. All the samples
ere tested in triplicate and template-negative reactions served as
ontrols.
.5. Western blotting
Western blotting was carried out using whole-cell lysates.
rieﬂy, total protein extraction was performed by homogenizing
ells in RIPA lysis buffer containing protease inhibitors (Protease
nhibitor Cocktail Set II, 539132, Calbiochem, EMD  Chemicals,
erck KGaA, Darmstadt, Germany) and phosphatase inhibitors
Roche, Germany). Lysates were incubated on ice for 30 min  and
entrifuged at 12,000g for 20 min  at 4 ◦C. Supernatants were then
uantiﬁed with Qubit® 3.0 Fluorometer (Life Technologies, Thermo
isher Scientiﬁc). Proteins were separated on 4–12% SDS–PAGE gel
Invitrogen, Thermo Fisher Scientiﬁc) and transferred to nitrocel-
ulose membranes (BioRAD, CA). Membranes were blocked for 1 h
n 5% non-fat dried milk in Tris-buffered saline (TBS) and incubated
vernight with antibodies against phospho-AKT (Ser473) (4060,
ell Signaling Technology, Denvers, CO, USA), or AKT (pan) (4691,
ell Signaling Technology), or phospho-GSK-3 (Ser9) (5558, Cell
ignaling Technology), or GAPDH (8884, Cell Signaling Technology).
he membranes were washed and incubated with anti-rabbit HRP
onjugated secondary antibodies (7074, Cell Signaling Technology).
ll the antibodies were used in accordance with the manufacturer’s
nstructions. The signal was captured using a ChemiDoc XRS (Bio-
AD). The level of expression of different proteins was evaluated
y Image J analysis software (Wayne Rasband, NIH, Bethesda, MD;
ttp://rsb.info.nih.gov/ij/). Total protein levels were normalized to
APDH levels, and p-AKT protein level was normalized to AKT.
.6. Data analysis and statistical analysis
Data processing and analysis were conducted using tools from
Q-manager (v1.2, Life Technologies, Thermo Fisher Scientiﬁc),
ataAssist software (v 3.01, Life Technologies, Thermo Fisher
cientiﬁc), Microsoft Excel and Prism GraphPad V5.0d software
GraphPad Software, CA). Statistical signiﬁcance of the observed
ifferences among the various experimental groups was calculated
sing a two-tailed unpaired Student’s t-test. P-values < 0.05 were
onsidered to be statistically signiﬁcant. In the ﬁgures, * and **
ndicate statistical signiﬁcance at p < 0.05 and 0.01, respectively.hemistry & Cell Biology 76 (2016) 1–11 5
3. Results
3.1. piRNAs are differentially expressed in cardiospheres,
cardiosphere-derived cells and cardiac ﬁbroblasts
To deﬁne the piRNA expression proﬁle we  isolated CS, CDC  and
CF from 5 biopsies (see Supplementary Table 1).
The primary cell cultures for each cell type showed a high homo-
geneity and a similar cell growth rate, and presented their typical
cell morphology (Fig. 1B). For each sample, after RNA extraction,
we veriﬁed RNA integrity and gDNA contamination (Fig. 1C).
To prove that the isolated cells belong to a particular cell type, we
analyzed the mRNA level of several markers, by quantitative Real-
Time RT-PCR (qRT-PCR) (Supplementary ﬁgure). CF, CDC and CS did
not express CD45 and cTNT, indicating, respectively, the absence of
hematological and cardiomyocytes contamination in the initial iso-
lation. Islet-1, a cardiac transcription factor, was not detected in any
group. Differently, CF, CDC and CS expressed the cardiac transcrip-
tion factor GATA-4, a crucial cardiac transcription factor, indicative
of their origin. Interestingly, in line with a previous study (Barile
et al., 2013), CS expressed higher levels of GATA4.
As shown in supplementary ﬁgure, we conﬁrmed in CF a higher
expression of CD90, Vimentin, DDR2, SMA  and CX43 than in CDC
and CS. Moreover CF and CDC did not express CD31, while CD31
mRNAs was  increased in 3D CS culture, as described (Li et al., 2010).
CDC and CS expressed mesenchymal stem cell markers, such as
CD90, CD105, and vimentin, but they had low levels of the ﬁbroblast
marker DDR2, excluding possible ﬁbroblasts contamination. The
CPC phenotype was  also conﬁrmed by the presence of mRNA for
the gap junction protein connexin 43. FLK1, a vascular endothelial
progenitor marker, used as a marker to characterize and isolate
cardiac stem/progenitor cells, was  overexpressed in CDC and CS, if
compared to CF.
We  determined the piRNA expression proﬁle (piRNome) in the
three cell types through microarray analysis. After quantile nor-
malization, the distributions of the data sets appeared nearly the
same (Fig. 1D). Microarray data of CS and CDC were compared to CF,
which were used as control because of their limited regenerative
potential (Smith et al., 2007).
Among the 23,000 piRNAs present in the dataset, we  found
15,311 piRNAs expressed in all the three cell types. When compar-
ing the piRNA expression levels between CS and CDC, we identiﬁed
2022 differentially expressed piRNAs (Fig. 2A, B; fold change ≥2.0,
p < 0.01). Among those, 641 piRNAs were upregulated in CS com-
pared to CDC (Supplementary Table 2), while 1381 piRNAs were
downregulated (Supplementary Table 3).
Looking at the differentially expressed piRNAs between CS and
CF, we found 255 upregulated and 780 downregulated piRNAs (fold
change ≥2, p < 0.01; Fig. 2A, B) (Supplementary Tables 4 and 5,
respectively).
Up to 181 piRNAs were differentially expressed in CDC when
compared to CF (fold change ≥2, p < 0.01; Fig. 2A, B), among which
52 were upregulated, whereas 129 were downregulated (Supple-
mentary Tables 6 and 7, respectively). Table 2 shows the partial
results for the differentially expressed piRNAs.
We used hierarchical clustering analysis to arrange the sam-
ples into groups based on their expression levels. This analysis
conﬁrmed the relationships among samples and also showed
systematic variations in the expression of piRNAs among the three
cell types (Fig. 2C). Interestingly, there are some piRNAs that are
overexpressed (DQ570332, DQ578426, DQ579582, DQ591185,
DQ592096) or downexpressed (DQ570024, DQ570256, DQ570326,
DQ570684, DQ570815, DQ570940, DQ571549, DQ571550,
DQ571873, DQ578783, DQ579896, DQ580140, DQ582231,
DQ582302, DQ582443, DQ582496, DQ583129, DQ584904,
DQ587263, DQ587751, DQ590873, DQ591537, DQ591538,
6 S. Vella et al. / The International Journal of Biochemistry & Cell Biology 76 (2016) 1–11
Table  1
Primers and probes for L1 transcripts.
Target Forward Reverse Probe
L1 5′ UTR #1 GAATGATTTTGACGAGCTGAGAGAA GTCCTCCCGTAGCTCAGAGTAATT AAGGCTTCAGACGATC
L1  5′ UTR #2 ACAGCTTTGAAGAGAGCAGTGGTT 
L1  ORF2 #1 TGCGGAGAAATAGGAACACTTTT 
L1  ORF2 #2 CAAACACCGCATATTCTCACTCA 
Table 2
No. of differentially expressed piRNAs in CS, CDC, and CF.
Fold change 2–4 Fold change 4–7 Fold change > 7 Total
CS vs CDC up 504 129 8 641
down 1236 107 38 1381
CS  vs CF up 237 17 1 255
down 694 74 12 780
CDC  vs CF up 45 7 0 52
down 121 7 2 129
Table 3
Deregulated piRNAs (fold change ≥ 4, p < 0.001) chromosome location.
upregulated piRNAs downregulated piRNAs
Chr no. CS vs CDC CS vs CF CDC vs CF CS vs CDC CS vs CF CDC vs CF
1 155 20 0 53 20 1
2  9 0 2 20 18 0
3  9 0 0 7 3 0
4  7 0 0 5 3 0
5  14 0 0 3 11 1
6  17 2 0 44 16 1
7  7 4 0 25 7 0
8  7 0 0 3 0 1
9  14 0 0 10 5 0
10  37 0 0 27 12 0
11  19 0 0 10 8 0
12  15 0 0 14 4 1
13  5 0 0 12 1 0
14  7 0 1 4 3 0
15  27 0 0 25 5 0
16  4 0 1 15 15 0
17  6 0 7 22 24 1
18  4 0 0 2 1 0
19  11 0 0 16 8 1
20  5 1 0 1 0 0
21  1 0 0 4 1 0
22  51 6 0 8 4 0
23  11 0 0 4 6 2
X  1 0 0 6 0 0
X
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C
species (Siomi et al., 2011). Among the different classes of trans-Y  1 0 0 0 0 0
, Y = sex chromosomes.
Q591926, DQ593270, DQ593595, DQ593707, DQ595111,
Q595878, DQ596280, DQ596850, DQ597074, DQ597396,
Q597397, DQ597403, DQ597941, DQ597968, DQ598180,
Q598181, DQ598182, DQ598204, DQ599003, DQ599147,
Q599786, DQ600950, DQ600951, DQ600952, DQ600961) in
oth CS vs CDC and in CS vs CF (fold change ≥4, p < 0.01; Fig. 3A and
), suggesting a functional role of these piRNAs in cardiospheres.
Q570326, DQ570339, DQ578783, DQ582302, DQ582496 were
pregulated in CDC vs CF and downregulated in CS vs CDC, sug-
esting that they are expressed at high levels in CDC. Moreover,
ome piRNAs are downregulated in both CS vs CF and in CDC vs CF
DQ578075, DQ579896, DQ581624) (Fig. 3B), suggesting a role in
ardiac ﬁbroblasts where they are expressed at higher levels.
The analysis of the chromosomal locations of the deregulated
iRNAs showed that they were distributed over all chromosomes
ut with higher density on some chromosomes (Table 3). Calcu-
ating the genomic density distribution of the upregulated piRNAs
number of piRNA loci per Mb  of individual chromosome) in CS vs
DC and in CS vs CF, we found some hotspots of piRNA loci on chr.AGTCTGCCCGTTCTCAGATCT TCCCAGCACGCAGC
TGAGGAATCGCCACACTGACT CTGTAAACTAGTTCAACCATT
CTTCCTGTGTCCATGTGATCTCA AGGTGGGAATTGAAC
22 (0.99 or 0.12, respectively, piRNA loci per Mb  of chromosome)
and chr. 1 (0.60 or 0.08, respectively), whereas the average on the
other chromosomes was 0.15 or 0.01, respectively (Fig. 3C and D).
The upregulated piRNAs in CDC vs CF were mainly located on chr.
17 (0.11 piRNA loci per Mb  of chromosome), in comparison with
the average on the other chromosomes (0.05) (Fig. 3E). In CS vs CDC
and in CS vs CF, the genomic density distribution of the downregu-
lated piRNAs revealed that many piRNA loci were on chr. 17 (0.27
and 0.29, respectively), compared to the average of the other chro-
mosomes (0.11 and 0.06, respectively) (Fig. 3C and D), meanwhile
the downregulated piRNAs in CDC vs CF were distributed on chr.
19 (0.017), in respect to the average on the other chromosomes
(0.003) (Fig. 3E).
These data are consistent with the idea that differentially
expressed piRNAs could be located on euchromatic or heterochro-
matic regions, respectively, and map  to discrete genomic clusters,
as previously reported (O’Donnell and Boeke, 2007).
3.2. Validation of the microarray data using real-Time RT-PCR
To verify the microarray data, we  randomly selected six dif-
ferentially expressed piRNAs (DQ582302, DQ570326, DQ571873,
DQ594975, DQ572313, and DQ586118) and validated their expres-
sion levels by qRT-PCR in three different CDC, CS and CF lines (n = 3
for each cell types).
The qRT-PCR results showed a consistently higher level of
changes in piRNA expression than the microarray data, most likely
because of the higher sensitivity of the assay and the employed nor-
malization procedures, consistent with the results of Dallas et al.
(Dallas et al., 2005) and Yuen et al. (Yuen et al., 2002).
In addition, the differences in the expression level were high-
lighted for those piRNA with Ct < 17 (DQ582302, DQ582496,
DQ570326) or Ct ≥ 31 (DQ594975, DQ572313, DQ586118), as pre-
viously described (Morey et al., 2006).
In the ﬁrst comparison (CDC vs CF), the microarray results
were conﬁrmed by qRT-PCR (DQ582302, DQ570326, DQ571873,
DQ594975, and DQ572313), with the exception of DQ586118
(Fig. 4A). In the second group of comparison (CS vs CF), the qRT-PCR
results for three piRNAs (DQ594975, DQ572313, DQ586118) were
in agreement with the microarray data. However, for DQ582302,
DQ570326, DQ571873, the two methods showed slightly different
results (Fig. 4B). It must point out that, although the inherent issues
about data normalization and different sensitivity as well as other
possible factors inﬂuencing the correlation of the results of the two
methods (Yuen et al., 2002; Chuaqui et al., 2002; Dallas et al., 2005;
Morey et al., 2006; Ach et al., 2008), in our experimental setting, the
pattern of expression modulation resulted to be fairly in agreement
by both qRT-PCR and microarray analysis.
3.3. Upregulated piRNAs target all the classes of LINE RT spread
over human genome, especially LINE-1
piRNA-machinery regulate transposable elements in severalposons, LTR and LINE represent their main targets (Ha et al., 2014).
Interestingly, it was demonstrated that piRNAs mediate sup-
pression of LINE-1 retrotransposons (RT) (Di Giacomo et al., 2013)
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sig. 3. Genomic distribution of the upregulated piRNAs.
enn diagram showing the number of upregulated (A) or downregulated (B) piRNA
n  human chromosomes in CS vs CDC (C), in CS vs CF (D) and in CDC vs CF (E) expre
nd this inhibition was  proven to be beneﬁcial in decreasing the
schemic damage of the heart (Lucchinetti et al., 2006).Based on this, we conducted a bioinformatics prediction of the
INE targets of each upregulated piRNAs searching in 100,000 base
tretches (1–100,000 bases of each human chromosome). The num-e three comparison groups (n = 5 for each group). Densities of deregulated piRNAs
s number of piRNA loci per megabase of DNA of each chromosome.
ber of targets of the upregulated piRNAs ranged from 20 to 483 with
an average of 88.4 per 100,000 bases (Table 4).Upregulated piRNAs targeted all the classes of LINE RT (LINE-1,
LINE-2 and CR1) spread over human genome (Table 5), especially
LINE-1. Thus, upregulation of piRNAs in CPC, mainly in CS, could
8 S. Vella et al. / The International Journal of Biochemistry & Cell Biology 76 (2016) 1–11
Fig. 4. piRNA deregulation is associated with L1 reduction and AKT signaling activation in cardiac progenitors.
Validation and comparison of microarray and qRT-PCR data. Values represent fold change in transcript copy number relative to control U6. Mean (± SD, n = 3) expression of
the  piRNAs DQ582302, DQ570326, DQ571873, DQ597096, DQ594975, DQ572313 and DQ586118, as measured by microarray and qRT-PCR in CDC vs CF (A) and in CS vs CF
(B).  Quantitative RT-PCR results for L1 RNA expression using the 5′ UTR #1 and #2 (C) or ORF2#1 and ORF2#2 (D) primer sets, analyzed in CDC, Cs and CF. The graphs show
the  fold change in L1 expression in CDC and CS comparing to CF. (E) Western Blot analysis of AKT, pAKT (S473), pGSK3 (S9) and GAPDH. (F) Densitometric analysis of the
ratio  pAKT/AKT showing statistically increased levels of the activated phosphor-AKT(S473) in CDC and CS, compared to the CF. Densitometric analysis of pAKT (G), AKT(H),
pGSK3b  (I), normalized to GAPDH. Densitometric analyses are expressed as means ± SD of three independent samples for each cell types. One star (*) indicates p < 0.05, while
two  stars (**) indicate p < 0.001, two-tailed Student’s test.
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Table  4
No. of targets of upregulated piRNAs (fold change ≥ 4, p < 0.001) distributed in bases 1–100,000 of the human chromosomes.
Upregulated piRNAs in CS Upregulated piRNAs in CDC Upregulated piRNAs in CF
Chr no. DQ570332 DQ578426 DQ579582 DQ591185 DQ592096 DQ570326 DQ570339 DQ578783 DQ582302 DQ582496 DQ579896 DQ578075 DQ581624
1 5 10 4 8 20 0 0 2 0 7 1 5 0
2  5 16 4 0 24 0 0 3 0 5 3 7 0
3  6 3 4 3 5 0 0 0 0 0 2 5 0
4  0 0 5 0 38 0 0 9 0 4 0 5 0
5  4 2 1 4 14 0 0 2 0 1 0 2 0
6  15 0 4 12 0 0 0 6 0 4 0 5 0
7  9 3 2 2 8 0 0 2 0 1 1 6 0
8  14 7 0 3 71 0 0 5 0 1 0 10 0
9  14 3 4 10 0 0 0 5 0 6 1 1 0
10  6 11 3 7 33 0 0 4 0 2 2 5 0
11  12 12 2 7 29 0 0 4 0 1 0 6 0
12  3 8 3 12 21 0 0 4 0 3 2 5 0
13  0 0 0 0 0 0 0 0 0 0 0 0 0
14  5 0 0 0 0 0 0 0 0 0 0 0 0
15  0 0 0 0 0 0 0 0 0 0 0 0 0
16  1 2 0 3 56 0 0 0 0 0 1 1 0
17  2 5 2 2 35 0 0 2 0 1 1 5 0
18  7 11 5 7 31 0 0 4 0 1 2 6 0
19  10 11 4 8 36 0 0 3 0 6 0 7 0
20  10 20 4 14 58 0 0 5 0 6 4 12 0
21  0 0 0 0 0 0 0 0 0 0 0 0 0
22  0 0 0 0 0 0 0 0 0 0 0 0 0
X  0 0 0 0 2 0 0 0 0 0 0 0 0
Y  0 0 0 0 2 0 0 0 0 0 0 39 0
X, Y = sex chromosomes.
Table 5
RT targets of upregulated piRNAs (fold change ≥ 4, p < 0.001) in the human chromosomes.a
Upregulated piRNAs in CS Upregulated piRNAs in CDC Upregulated piRNAs in CF
RT DQ570332 DQ578426 DQ579582 DQ591185 DQ592096 DQ570326 DQ570339 DQ578783 DQ582302 DQ582496 DQ579896 DQ578075 DQ581624
CR1 5 3 1 6 6 0 0 1 0 3 1 3 0
LINE-1 115 119 41 84 428 0 0 48 0 41 12 97 0
0 
tive t
i
v
3
s
s
2
A
s
q
w
O
e
h
m
c
d
C
s
(
t
m
pLINE-2 8 2 9 12 49 0 
a All targets presented belong to the LINE class. The numbers indicate the cumula
nduce the inhibition of LINE-1 expression and, consequently, acti-
ate AKT signaling (Lucchinetti et al., 2006).
.4. piRNA deregulation is associated with L1 reduction and AKT
ignaling activation in cardiac progenitors
Considering the important role of the L1 inhibition and the AKT
ignaling activation in reducing heart damage (Lucchinetti et al.,
006), we ﬁrst compared L1 mRNA level in the three cell types.
mong different methods available for the analysis of L1 expres-
ion (Munoz-Lopez et al., 2012), we chose qRT-PCR. To accurately
uantify L1 mRNA levels, two different sets of primers and probes
ere used to amplify 67- and 64-bp amplicons from the 5′-UTR and
RF2 regions of L1, respectively.
Notably as expected, and as previously demonstrated (Coufal
t al., 2009), the level of L1 mRNA obtained using the ORF2 set is
igher than the level obtained with the 5′-UTR set (data not shown).
As shown in Fig. 4C and D, in general, L1 transcript levels were
arkedly decreased in CDC and CS, in comparison to CF (p < 0.01),
onﬁrming the in silico prediction.
Next, we investigated the activation status of AKT pathway by
etermining the expression of phosphorylated AKT (S473) in CDC,
S and CF (n = 3 for each cell types). Phosphorylated AKT levels were
igniﬁcantly higher in CDC and CS (more than twofold) than in CF
p < 0.01, Fig. 4E–H).As part of this experiment, we examined whether a representa-
ive AKT downstream signaling molecule, such as GSK3, was  also
odulated. GSK3 is a kinase whose activity is inhibited by phos-
horylation of Ser9 by phospho-AKT. In CDC and, especially, in CS11 0 5 7 32 0
otal repeats of a RT present in 1–100,000 bases of human chromosomes.
(p < 0.05), the phosphorylation of AKT (Ser473) was associated with
the phosphorylation of GSK3 (Ser9) (Fig. 4E and I).
These results unequivocally demonstrated that, in cardiac pro-
genitors, the reduction of L1 expression is accompanied by a higher
activation of AKT pathway.
4. Discussion
In the last decade CPC have attracted great interest as an in vitro
model of a stem cell niche-like microenvironment (Barile et al.,
2013) and as a possible source for myocardial regenerative thera-
pies (Makkar et al., 2012). Because of their use in clinical trials, many
efforts have been made to better characterize CPC, particularly
focusing on the impact of age and disease on cardiac progenitors’
features.
Although it has been shown that c-KIT expression, CDC prolif-
eration and their regenerative potential declined with advancing
age (Capogrossi, 2004; Mishra et al., 2011), CDC can be successfully
produced from adults (Chan et al., 2012; Hsiao et al., 2013; Moretti
et al., 2006) and they are functionally competent (Simpson et al.,
2012), representing a promising new approach to treat patients
with ischemic heart failure.
Recently, several studies highlighted the role of ncRNAs in car-
diac regeneration and heart diseases (Wu  et al., 2013), so that
miRNA mimics and/or inhibitors have been envisaged to treat heart
diseases (van Rooij and Olson, 2012). PiRNAs are small ncRNAs
associated with PIWI proteins, which are expressed not only in
germ but also somatic cells of various organs, including brain, liver
and heart (Law et al., 2013; Rajan et al., 2014). PiRNAs are able to
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odulate transposons expression (Kim, 2006) and key molecular
athways (Watanabe et al., 2006) as AKT signaling. In particular,
t has been shown that abundant piRNA expression induces AKT
ctivation (Law et al., 2013). Moreover, Rajan et al. showed as both
iRNAs and piRNAs alter AKT pathway in heart diseases (Rajan
t al., 2014). AKT is a powerful survival signal, and it plays a vital
unction in heart enhancing the proliferation of myocardial stem
nd progenitor cells and cardiomyocyte survival (Fujio et al., 2000;
atsui et al., 1999; Matsui et al., 2001; Rajan et al., 2014).
Remarkably, the AKT signaling pathway is activated by many
ardioprotective ligand-receptor systems (Baines et al., 1999;
uerke et al., 1995; Dudek et al., 1997; Hirota et al., 1999; Kulik
t al., 1997; Li et al., 1999; Oh et al., 1998). Notably, the deregulation
f AKT pathway is involved in heart remodelling and decompensa-
ion, contributing to the development of heart diseases (Dent et al.,
007).
Since several evidences have shown the central role of this path-
ay in myocardial biology, AKT has been considered an interesting
arget for controlling many important aspects of myocardial bio-
ogical processes and for improving cardiac repair. Despite many
fforts have been done, there were several limitations in the AKT
anipulation (Sussman, 2007; Sussman et al., 2011). For this rea-
on, in-depth studies of the molecular mechanisms underlying the
egulation of AKT have been necessary.
Interestingly, it was demonstrated that the AKT signaling path-
ay is activated by the inhibition of LINE-1, leading to a decrease
f cardiac ischemic damage (Lucchinetti et al., 2006). All these evi-
ences reveal how piRNAs are crucial players in the regulatory
etwork governing cardiac physiology and pathology. Indeed, very
ecently, Rajan and coworkers showed an altered piRNA expres-
ion in an animal model of cardiac hypertrophy and identiﬁed the
resence of a speciﬁc piRNA in sera of patients with myocardial
nfarction, suggesting a role of piRNAs in the retrotransposon mech-
nisms activated during several cardiac pathologies (Rajan et al.,
016).
In this scenario, our study provides a full and comprehensive list
f piRNAs expressed in CPC, describing differentially expressed piR-
As within the three cell types, irrespectively of heart diseases. To
ur knowledge, this is the ﬁrst report of piRNA signature in cardiac
rogenitors, suggesting a role for piRNAs in cardiac regenerative
otential.
Microarray results revealed a set of differentially expressed piR-
As, with 641 upregulated and 1301 downregulated piRNAs in CS
ompared to CDC, while 255 and 708 piRNAs resulted up- and
own-regulated, respectively, comparing CS to CF. We  also iden-
iﬁed 181 piRNAs that are overexpressed and 129 downexpressed
n CDC in respect to CF.
Intriguingly, based on piRNA proﬁles, hierarchical clustering
nalysis clearly arranges samples showing systematic variations in
he expression of piRNAs within the three cell types. In addition,
ome piRNAs were highly expressed only in one of the three cell
ypes analysed, suggesting their role in the cell phenotype deter-
ination.
Bioinformatics analysis also showed that the deregulated piR-
As were distributed overall the genome with higher density on
ew chromosomes, suggesting that piRNAs are organized in discrete
enomic clusters, as reported (O’Donnell and Boeke, 2007). More-
ver, in silico prediction indicates that the most upregulated piRNAs
arget transposons spread among the human chromosomes, espe-
ially LINE-1. This prediction was conﬁrmed by qRT-PCR, which
ighlighted a decrease of L1 transcripts in CDC and CS, in compar-
son to cardiac ﬁbroblasts. The L1 reduction is also associated to
n activation of AKT signaling, as shown by Western Blot analysis.
hese data are in line with the known piRNA-mediated reduction of
INE-1, which inﬂuences AKT signaling pathway (Lucchinetti et al.,
006; Rajan et al., 2014). However, the mechanisms integrating piR-hemistry & Cell Biology 76 (2016) 1–11
NAs with crucial molecular pathways are still poorly understood
and the pathophysiological signiﬁcance of piRNAs in heart is not
currently known.
The present study identiﬁes for the ﬁrst time a cardiac piRNome
which may  be, at least partially, responsible of the different regen-
erative potential and may  shed new lights on the understanding the
complex molecular mechanisms of cardiac regeneration. Although
the present study indicates a cell-type speciﬁc piRNA signature,
future functional studies will be necessary in order to unravel the
mechanisms in which these non-coding RNAs are involved, and to
determine their role in cardiac regeneration.
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